Eleni Tsakiri | Foundations of Neuroscience | Best Researcher Award

Dr. Eleni Tsakiri | Foundations of Neuroscience | Best Researcher Award

Dr. Eleni Tsakiri |  National and Kapodistrian University of Athens Medical School | Greece

Dr. Eleni Tsakiri is a distinguished Molecular Biologist whose research centers on the molecular mechanisms of aging, proteostasis, and neurodegeneration. She earned her Ph.D. in Biology from the National and Kapodistrian University of Athens (NKUA) with a thesis on proteome homeostasis and its alterations during aging, following her M.Sc. in Cell Biology and Biophysics and a B.Sc. in Molecular Biology and Genetics. Dr. Tsakiri has held multiple postdoctoral positions at leading Greek institutions, including the Medical School of NKUA and the Biomedical Research Center “Alexander Fleming,” where she contributed to projects on proteasome regulation, Tau aggregation, and ribosome-mediated cell competition. Currently, she serves as a Postdoctoral Researcher at the Laboratory of Physiology, NKUA, focusing on neurodegeneration and aging under an ERC-funded project. Her research is supported by competitive grants such as the Hellenic Foundation for Research and Innovation (HFRI). She has supervised undergraduate, master’s, and doctoral students and actively collaborates with prominent researchers in Greece and abroad. Dr. Tsakiri’s contributions are reflected in her 24 published documents, 730 citations, and an h-index of 15, highlighting her impact in molecular biology and aging research.

Profiles: Scopus | Google Scholar | Research Gate | LInked In

Featured Publications

  • Tsakiri, E. N., Sykiotis, G. P., Papassideri, I. S., Terpos, E., Dimopoulos, M. A., & others. (2013). Proteasome dysfunction in Drosophila signals to an Nrf2‐dependent regulatory circuit aiming to restore proteostasis and prevent premature aging. Aging Cell, 12(5), 802–813.

  • Tsakiri, E. N., Sykiotis, G. P., Papassideri, I. S., Gorgoulis, V. G., Bohmann, D., & others. (2013). Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress. The FASEB Journal, 27(6), 2407–2419.

  • Tsakiri, E. N., & Trougakos, I. P. (2015). The amazing ubiquitin-proteasome system: Structural components and implication in aging. International Review of Cell and Molecular Biology, 314, 171–237.

  • Tsakiri, E. N., Iliaki, K. K., Höhn, A., Grimm, S., Papassideri, I. S., & Grune, T. (2013). Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster. Free Radical Biology and Medicine, 65, 1155–1163.

  • Tsakiri, E. N., Gumeni, S., Iliaki, K. K., Benaki, D., Vougas, K., Sykiotis, G. P., et al. (2019). Hyperactivation of Nrf2 increases stress tolerance at the cost of aging acceleration due to metabolic deregulation. Aging Cell, 18(1), e12845.

Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Dr. Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Dr. Ricardo S. Osorio is a tenured Associate Professor of Psychiatry and Radiology at NYU Grossman School of Medicine, where he directs the Healthy Brain Aging and Sleep Center and serves as Director of the Biomarker Core within the NYU Alzheimer’s Disease Research Center. A physician-scientist, Dr. Osorio investigates the interplay of sleep, vascular, and inflammatory mechanisms in Alzheimer’s disease, integrating multimodal biomarkers, neuroimaging, and detailed clinical phenotyping. He has led several landmark studies, including trials on sleep apnea, amyloid and tau accumulation, brain energetics, and locus coeruleus dysfunction, exploring how sleep and metabolic factors influence cognitive decline and neurodegeneration. His work has significantly advanced translational biomarker development, assay harmonization, and inclusive recruitment in aging research. Dr. Osorio has published over 130 peer-reviewed articles in top journals such as JAMA Neurology, Annals of Neurology, Sleep, Alzheimer’s & Dementia, Lancet, and Brain, contributing to more than 8,369 citing documents, with a total citation count of 9,893 and an h-index of 44. He serves on multiple editorial boards, including Sleep Medicine Reports, and has provided expert peer review for leading journals worldwide. His collaborative network spans the NYU Alzheimer’s Disease Research Center, Mount Sinai, the ENIGMA-Sleep Consortium, and numerous national and international aging and sleep research initiatives, mentoring the next generation of clinician-scientists while shaping the field of sleep and neurodegeneration.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

  1. Author(s). (Year). Disordered sleep and painful diabetic neuropathy (PDN): A review of the literature on pathophysiology, pharmacologic and nonpharmacologic treatment options, and future directions. Journal Name, Volume(Issue), pages.

  2. Author(s). (2025). EEG slow oscillations and overnight spatial navigational memory performance in CPAP-treated obstructive sleep apnea. Sleep, Volume(Issue), pages.

  3. Author(s). (2025). High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer’s disease dementia. Alzheimer’s & Dementia, Volume(Issue), pages.

  4. Author(s). (2025). Impact of Alzheimer’s disease on sleep in adults with Down syndrome. Alzheimer’s & Dementia, Volume(Issue), pages.

  5. Author(s). (2025). Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tau. Journal of Clinical Investigation, Volume(Issue), pages.

  6. Author(s). (2025). The stability of slow-wave sleep and EEG oscillations across two consecutive nights of laboratory polysomnography in cognitively normal older adults. Journal of Sleep Research, Volume(Issue), pages.

  7. Author(s). (2025). Two-year longitudinal outcomes of subjective cognitive decline in Hispanics compared to non-Hispanic Whites. Journal of Geriatric Psychiatry and Neurology, Volume(Issue), pages.

  8. Author(s). (Year). Enhancing sleep, wakefulness, and cognition with transcranial photobiomodulation: A systematic review. Journal Name, Volume(Issue), pages.

  9. Author(s). (2024). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Journal of Alzheimer’s Disease, Volume(Issue), pages.

  10. Author(s). (2024). The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people. Immunity and Ageing, Volume(Issue), pages.

Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Dr. Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Dr. Yu Zhou is a postdoctoral researcher at Army Engineering University, specializing in the intersection of neuroscience, computer vision, and target detection. His research primarily focuses on deceptive visual design for both human and machine perception, exploring how visual stimuli can influence detection, recognition, and cognitive processing. Zhou has conducted pioneering studies on camouflage and optical deception, utilizing EEG-based brain functional network analysis to evaluate target visibility and cognitive responses. His work integrates principles from weapon science, biomedical engineering, and computer science to develop comprehensive models of visual perception and deception. Representative publications include investigations into neural responses to camouflage targets with varying exposure signs, the impact of color differences on brain activation patterns, and feasibility assessments of optical camouflage effects. Through these studies, he contributes to a deeper understanding of how visual designs can manipulate human attention and computer vision systems, providing actionable insights for defense technology applications. Zhou’s research emphasizes rigorous quantitative evaluation methods, leveraging neurophysiological data to inform the design of effective deceptive visual patterns. With an h-index of 2 and multiple citations, his work demonstrates a growing influence in fields spanning neuroscience-informed computer vision, perceptual deception, and applied optical camouflage.

Profiles: Scopus | Reasearch Gate

Featured publication

Author(s). (2024). Neural responses to camouflage targets with different exposure signs based on EEG. Neuropsychologia.

Congbo Cai | Neurotechnology | Best Researcher Award

Prof. Dr. Congbo Cai | Neurotechnology | Best Researcher Award

Prof. Dr. Congbo Cai | Xiamen University | China

Professor Congbo Cai is a distinguished researcher at the School of Electronic Science and Technology, Xiamen University, specializing in advanced Magnetic Resonance Imaging (MRI) technology development. His research encompasses ultra-fast imaging, multi-parametric quantitative MRI, deep learning reconstruction, novel neuroimaging techniques, and quantitative medical image analysis. He has led and contributed to numerous high-impact projects, including national key R&D programs, NSFC key projects, and international cooperative projects, with funding totaling several million yuan. His innovations include pioneering high-entropy encoding and overlapping-echo designs, enabling rapid, high-fidelity MRI mapping, and integrating physics-informed deep learning for enhanced image reconstruction and clinical applications. Professor Cai has published over 80 papers in leading journals such as NeuroImage, IEEE Transactions on Medical Imaging, and Medical Image Analysis. He holds 12 patents and serves on editorial boards, including Health and Metabolism, and as a guest editor for Frontiers in Neuroscience. His professional contributions extend to active membership and leadership roles in major MRI societies. His work has garnered significant academic recognition, with a citation count exceeding 2,300 across 872 documents, an h-index of 25, and an i10-index of 55. Professor Cai’s research continues to advance MRI science, bridging cutting-edge technology and clinical translation.

Profiles: Scopus | Google Scholar | Research Gate | Linked In

Featured publications

  • Author(s). (2018). Accelerating multi-slice spatiotemporally encoded MRI with simultaneous echo refocusing. Journal of Magnetic Resonance.

  • Author(s). (2018). Single-shot T2 mapping using overlapping-echo detachment planar imaging and a deep convolutional neural network. Magnetic Resonance in Medicine.

  • Author(s). (2018). Referenceless distortion correction of gradient-echo echo-planar imaging under inhomogeneous magnetic fields based on a deep convolutional neural network. Computers in Biology and Medicine.

  • Author(s). (2018). Weighted total variation using split Bregman fast quantitative susceptibility mapping reconstruction method. Chinese Physics B.

  • Author(s). (2018). Simultaneous single- and multi-contrast super-resolution for brain MRI images based on a convolutional neural network. Computers in Biology and Medicine.

  • Author(s). (2018). Motion-tolerant diffusion mapping based on single-shot overlapping-echo detachment (OLED) planar imaging. Magnetic Resonance in Medicine.

Nasar Ata | Neurology | Best Researcher Award

Mr. Nasar Ata | Neurology | Best Researcher Award

Dr. S. M. Nasar Ata is a researcher in the Department of Neurology at Henry Ford Hospital, Detroit, USA, specializing in artificial intelligence applications in neuroscience. His work focuses on developing machine learning and soft computing–based algorithms such as CNN, ANN, SVM, and MLR for detecting and predicting brain-based disorders, including Multiple Sclerosis. He integrates metabolomics and imaging clinical data to identify biomarkers and construct predictive models for neurological and metabolic diseases. Dr. Ata collaborates with research centers such as JNMC and IBRC AMU on brain tumor prediction from MRI data and with RCDR AMU on diabetes-related model development. His research contributions include several submitted papers on metabolite prediction, deep learning in brain tumor detection, and molecular mechanisms underlying neurodegeneration and cancer. He has also authored the textbook Basics of Bio-Sciences and actively participates in scientific discussions and editorial work. With 3 published documents, 7 citations, and an h-index of 2, Dr. Ata’s growing research profile reflects his commitment to advancing data-driven neurological diagnostics through AI and biostatistical innovation.

Profiles: Scopus | Research Gate

Featured Publication

Corrigendum to “Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data” [Multiple Sclerosis and Related Disorders, 92, 105942 (2024)]. (2024). Multiple Sclerosis and Related Disorders, 95, 106321.

Mansoor Showkat | Computational Neuroscience | Best Researcher Award

Mr. Mansoor Showkat | Computational Neuroscience | Best Researcher Award

Mr. Mansoor Showkat | SKUAT-Kashmir | India

Mansoor Showkat is a researcher in Plant Biotechnology with an M.Sc. from the University of Agricultural Sciences, Bangalore, and a B.Sc. (Hons.) in Horticulture from Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir. His research expertise spans molecular biology, computational biology, bioinformatics, and tissue culture, with particular emphasis on antifungal compound analysis, gene transformation, and plant-pathogen interactions. Mansoor has contributed to several peer-reviewed publications and book chapters, focusing on the in-silico and in-vitro evaluation of bioactive compounds such as cordycepin, molecular mechanisms of stress responses, and secondary metabolite profiling in plants. His research projects include genetic transformation studies, metabolomics-based investigations, and the use of omics tools for crop improvement. He has actively participated in numerous international workshops, conferences, and webinars related to biotechnology, bioinformatics, and genomics. Mansoor has achieved significant academic recognition, including national rankings in competitive examinations by the Indian Council of Agricultural Research. His scientific impact is reflected by a citation count of 15, an h-index of 2, and an i10-index of 0, highlighting his growing contribution to molecular and agricultural biotechnology research.

Featured Publications

  1. Showkat, M., Narayanappa, N., Umashankar, N., & Saraswathy, B. P., et al. (2024). Optimization of fermentation conditions of Cordyceps militaris and in silico analysis of antifungal property of cordycepin against plant pathogens. Journal of Basic Microbiology, 64(10), e2400409.

  2. Fatimah, N., Ashraf, S., R. U., K. N., Anju, P. B., Showkat, M., Perveen, K., Bukhari, N. A., et al. (2024). Evaluation of suitability and biodegradability of the organophosphate insecticides to mitigate insecticide pollution in onion farming. Heliyon, 10(12).

  3. Margay, K. A. A. A. R., Ashraf, S., Fatimah, N., Jabeen, S. G., & Showkat, M., et al. (2024). Plant circadian clocks: Unravelling the molecular rhythms of nature. International Journal of Plant and Soil Science, 36(8), 596–617.

  4. Margay, A. R., Ashraf, S., Fatimah, N., Jabeen, S. G., Showkat, M., R. U., K. N., Gani, A., et al. (2024). Harnessing brassinosteroids for heat resilience in wheat: A comprehensive study.

  5. Showkat, M., Nagesha, N., Ashraf, S., Nayana, K., Bashir, S., Nair, A. S., et al. (2024). Cordycepin: A molecular Trojan horse against Fusarium oxysporum f. sp. cubense—A computational perspective.

Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Prof. Dr. Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Prof. Dr. Elzbieta Paszynska | Poznan University of Medical Sciences | Poland

Professor Elzbieta Paszynska is a distinguished expert in dentistry, serving as Chair of the Department of Integrated Dentistry and Chair of Community Dentistry at Poznan University of Medical Sciences. Her academic focus includes community dentistry, adult comprehensive dental treatment, dental materials, and clinical research in oral health, particularly in patients with eating disorders. She has led numerous significant research projects, including studies on salivary biomarkers, oral health status in eating disorders, and the caries-preventive effects of hydroxyapatite toothpaste in children and adults, collaborating with multiple international institutions. Her research has contributed to over 70 scientific documents with more than 598 citations and an h-index of 13. She has published high-impact works in journals such as Scientific Reports, Frontiers in Public Health, Frontiers in Psychiatry, Nutrients, and the Journal of Dentistry. Her contributions include interdisciplinary projects integrating dentistry, ethics, and public health, and she has coordinated large-scale EU-funded projects and international collaborations. Her work has been recognized with multiple institutional and national awards for scientific excellence, teaching, and professional contributions to dentistry, as well as honors from professional dental associations. She is an active member of national boards and promotes innovation in dental education and research.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • Obesity and central accumulation of fat in school-age children with attention-deficit/hyperactivity disorder. (2025). Scientific Reports.

  • Miescher’s Cheilitis as a Diagnostic and Therapeutic Challenge—A Case Report. (2025). Medicina, Kaunas, Lithuania.

  • Prevalence of Toothache in Adults: A Meta-Analysis of Worldwide Studies. (2025).

  • Pain experience and behavior management: efficacy of photobiomodulation as an adjunct to local anesthesia in MIH patients—a randomized split-mouth clinical study. (2025). Frontiers in Neurology.

  • Clinical evidence of caries prevention by hydroxyapatite: An updated systematic review and meta-analysis. (2025).

Hiroshi Nagase | Neuropharmacology | Best Researcher Award

Prof. Hiroshi Nagase | Neuropharmacology | Best Researcher Award

Prof. Hiroshi Nagase | University of Tsukuba | Japan

Prof. Hiroshi Nagase is a distinguished Japanese scientist recognized for his pioneering contributions to medicinal chemistry and drug discovery. He earned his B.S., M.S., and Ph.D. degrees in Chemistry from Nagoya University, Japan, and later served as a Visiting Scientist at the University of Minnesota’s Department of Medicinal Chemistry. Dr. Nagase began his professional career at Toray Industries Inc., where he advanced from Researcher to Director in the Basic Research Laboratories. He later joined Kitasato University’s School of Pharmacy as a Professor and subsequently served as a Principal Investigator and Professor at the International Institute for Integrative Sleep Medicine (IIIS) under the World Premier International Research Center Initiative at the University of Tsukuba, where he now holds the title of Professor Emeritus. His academic and research influence extended through adjunct professorships at the University of Tokyo, the University of Nagasaki, Toyohashi Polytechnic College, and Nagoya University. Dr. Nagase has authored 39 scientific documents, which have collectively garnered 279 citations from 189 sources, reflecting his substantial impact on the field. With an h-index of 10, his research continues to inspire advancements in medicinal chemistry, neuropharmacology, and therapeutic innovation.

Profiles: Scopus | Research Gate

Featured Publication

Nagase, H. (2025). Development of novel bioactive alkaloids based on specific reactions of the 4,5-epoxymorphinan framework. Synlett.

[Authors not listed]. (2025). Delta opioid receptor agonists activate PI3K–mTORC1 signaling in parvalbumin-positive interneurons in mouse infralimbic prefrontal cortex to exert acute antidepressant-like effects. Molecular Psychiatry.

Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Ms. Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Ms. Priyadharshini Veeralakshmanan | Amrita Vishwa Vidyapeetham | India

Ms. Priyadharshini Veeralakshmanan is a dedicated PhD scholar at Amrita Vishwa Vidyapeetham, specializing in Medical Oncology with a focus on Breast Cancer Immunology and the immunosuppressive tumour microenvironment (TME), particularly in Triple-Negative Breast Cancer (TNBC). Her doctoral research involves a Phase 2/3 open-label pilot clinical trial to evaluate neoadjuvant metronomic chemotherapy for modulating the TME and enhancing chemo- and immunotherapy responses, quantifying immunosuppressive cells and tumour-infiltrating lymphocytes from blood and tumour tissue. She holds an M.Sc. in Physician Assistant (Medical Oncology) and a B.Sc. in Physician Assistant (General Medicine), with extensive clinical training in oncology, hematology, surgical oncology, radiation oncology, and palliative care. Priyadharshini has strong expertise in flow cytometry, cell culture, in vitro drug testing, cytotoxicity assays, systematic reviews, meta-analysis, and clinical trial design, using advanced analytical tools such as FlowJo, SPSS, and GraphPad Prism. She has authored several publications, with an h-index of 3, over 7 documents, and more than 50 citations. A member of ESMO, ASCO, and I-OSI, she is committed to advancing cancer research, translating innovative findings into clinical practice to improve patient outcomes globally.

Profiles: Orcid | Linked In

Featured publications

Veeralakshmanan, P., Jose, W. M., Udayakumaran, S., Bindhu, M. R., Dutta, D., Rajesh, K., Kavalagunta, S., Bhaskaran, R., Haridas, N. K., Rakesh, M. P., et al. (2025). Multimodal management and outcome of pediatric and adolescent malignant central nervous system tumors: A single‐center retrospective study. Malignancy Spectrum.

Surendran, H. P., Sah, S. K., Veeralakshmanan, P., Nair, P., Ashok, H. P., Unnikrishnan, M. K., Kalavagunta, S., Sasidharan, A., Chandran, D., Poornachary, N. M., et al. (2025). Efficacy of hippocampal avoidance whole brain radiotherapy to preserve the cognitive functions among brain metastasis patients: Systematic review and meta-analysis. Neurology India, 73(5), 715–725.

Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | University of California San Diego | United States

Dr. Irene Litvan, MD, is the Tasch Endowed Professor of Neurology and Director of the Parkinson and Other Movement Disorders Center at the University of California, San Diego. She is internationally recognized for her pioneering work in movement disorders, particularly Parkinson’s disease and related neurodegenerative conditions. As a leading clinician-scientist, she has directed major multicenter and international initiatives to develop clinical and neuropathologic diagnostic criteria, identify disease biomarkers, and advance therapeutic interventions. Her extensive research spans epidemiologic, genetic, and clinico-pathologic correlation studies that have significantly deepened the understanding of movement disorders. Dr. Litvan’s scholarly impact is reflected in 6 published documents, 10 citations, and an h-index of 1. Throughout her distinguished career, she has received consistent funding support from national and international agencies, industry collaborations, and philanthropic organizations. Beyond her research, she has served as a dedicated mentor, shaping the next generation of neurologists and neuroscientists. Dr. Litvan also leads the UC San Diego Parkinson and Other Movement Disorders Center, fostering clinical excellence and research innovation aimed at improving diagnosis, management, and quality of life for individuals with Parkinson’s disease and other movement-related neurological disorders.

Featured Publications

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., et al. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders, 30(12), 1591–1601.

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55(11), 1621–1626.

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707.

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356.

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS–SPSP international workshop. Neurology, 47(1), 1–9.

Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Movement Disorders, 32(6), 853–864.